Novigenix SA, corporate

Novigenix SA,

09.09.2022 - 07:03:03

Novigenix Announces Discovery of Liquid Biopsy Immunotherapy Response Biomarkers in Metastatic Melanoma

09.09.2022 CET/CEST Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at

Language: English Company: Novigenix SA

Switzerland EQS News ID: 1438881 ? End of News DGAP News Service